Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-20-063359

Options or other derivatives

  • Chief Financial Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Estepan Ian Michael · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-12-14 Grant or award : show line 1 in the form Stock option (right to buy) +25,000 $169.54 2030-12-14 25,000 25,000 D
Loading xslF345X03/doc4.xml…